Cargando…

The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature

In order to clarify the role of mitomycin (MMC) in the treatment of NSCLC, we performed a systematic review of the literature and qualitatively assessed the selected studies using the ELCWP and Chalmers scales. 5 trials (202 patients) assessed the activity of MMC as single-agent chemotherapy in NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sculier, J P, Ghisdal, L, Berghmans, T, Branle, F, Lafitte, J J, Vallot, F, Meert, A P, Lemaitre, F, Steels, E, Burniat, A, Mascaux, C, Paesmans, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363891/ https://www.ncbi.nlm.nih.gov/pubmed/11336463 http://dx.doi.org/10.1054/bjoc.2001.1742

Ejemplares similares

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
por: Martin, B, et al.
Publicado: (2003)

Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis
por: Meert, Anne-Pascale, et al.
Publicado: (2001)

Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis
por: Martin, B, et al.
Publicado: (2004)

Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results
por: Mascaux, C, et al.
Publicado: (2006)

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
por: Meert, A-P, et al.
Publicado: (2002)

The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature
por: Meert, A-P, et al.
Publicado: (2003)

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
por: Mascaux, C, et al.
Publicado: (2005)

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
por: Sculier, J-P, et al.
Publicado: (2000)

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer
por: Berghmans, Thierry, et al.
Publicado: (2017)

A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics
por: Sculier, J P, et al.
Publicado: (2001)

Invasive mechanical ventilation in cancer patients: prior non-invasive ventilation is a poor prognostic factor
por: Meert, A, et al.
Publicado: (2010)

VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study
por: Berghmans, Thierry, et al.
Publicado: (2015)

Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party
por: Berghmans, T, et al.
Publicado: (2007)

Are Intensive Cares Worthwhile for Breast Cancer Patients: The Experience of an Oncological ICU
por: Destrebecq, Virginie, et al.
Publicado: (2016)

Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party
por: Berghmans, Thierry, et al.
Publicado: (2015)

Advances in target therapy in lung cancer
por: Sculier, Jean-Paul, et al.
Publicado: (2015)

Updates in oncology
por: Sculier, Jean-Paul, et al.
Publicado: (2014)

Continuous Renal Replacement Therapy for Acute Renal Failure in Patients with Cancer: A Well-Tolerated Adjunct Treatment
por: Fischler, Rebecca, et al.
Publicado: (2016)

Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase
por: Wang, X, et al.
Publicado: (1999)

5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer
por: Sobrero, A, et al.
Publicado: (2001)

A unique cytosolic activity related but distinct from NQO1 catalyses metabolic activation of mitomycin C
por: Joseph, P, et al.
Publicado: (2000)

Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer
por: Propper, D J, et al.
Publicado: (2000)

Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study
por: Hong, R L, et al.
Publicado: (1999)

Phase I study of the mitomycin C analogue BMS-181174.
por: Macaulay, V. M., et al.
Publicado: (1998)

Mitomycin C, vinblastine and cis-platin. An active regimen for advanced non-small cell lung cancer.
por: Giaccone, G., et al.
Publicado: (1987)

Enhancement of photodynamic therapy by mitomycin C: a preclinical and clinical study.
por: Baas, P., et al.
Publicado: (1996)

Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.
por: van Geel, I. P., et al.
Publicado: (1995)

A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10–2 trial)
por: Murofushi, Keiko Nemoto, et al.
Publicado: (2022)

Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C
por: Whitehouse, P A, et al.
Publicado: (2003)

Variations in exposure to mitomycin C in an in vitro colony-forming assay.
por: Slee, P. H., et al.
Publicado: (1986)

Effectiveness of isolated liver perfusion with mitomycin C in the treatment of liver tumours of rat colorectal cancer.
por: Marinelli, A., et al.
Publicado: (1991)

Critically ill cancer patient’s resuscitation: a Belgian/French societies’ consensus conference
por: Meert, Anne-Pascale, et al.
Publicado: (2021)

Intra-Operative Mitomycin-C as Adjuvant Therapy in External and Endonasal Dacryocystorhinostomy: Systematic Review and Meta-Analysis
por: Sousa, Tamata T. S., et al.
Publicado: (2020)

Applications of Mitomycin C in Cornea and External Disease
por: Crespo, Marcos A., et al.
Publicado: (2023)

Effect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell line.
por: Datta, S. N., et al.
Publicado: (1997)

A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.
por: Hickish, T. F., et al.
Publicado: (1998)

Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
por: Ligtenberg, M J L, et al.
Publicado: (1999)

Chemopotentiation of mitomycin C cytotoxicity in vitro by platinum complexes.
por: Teicher, B. A., et al.
Publicado: (1985)

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
por: Ellis, P. A., et al.
Publicado: (1995)

Focal Urethral Stricturing Following Intraurethral Mitomycin-C Gel and the Use of a Penile Clamp
por: Stanford, Richard F. J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_huf1eobisd3rg49d9vr535vfsk